Recent Advances in Nanotherapeutics for Multiple Myeloma
Anticancer therapies cannot be included in a one-size-fits-all scenario; it is imperative to adapt therapies to the tumor molecular profile and most importantly to develop target-specific therapeutics. Nanotherapeutics can combine molecular imaging with molecular therapy in order to provide the maxi...
Main Authors: | Daniela Iannazzo, Roberta Ettari, Salvatore Giofrè, Ali H. Eid, Alessandra Bitto |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/11/3144 |
Similar Items
-
Lipid-engineered nanotherapeutics for cancer management
by: Alicia Fernandez-Fernandez, et al.
Published: (2023-03-01) -
Recent Advances in Nano-Therapeutic Strategies for Osteoarthritis
by: Xinjing Guo, et al.
Published: (2022-06-01) -
Optimized Liposomal Delivery of Bortezomib for Advancing Treatment of Multiple Myeloma
by: Chi Zhang, et al.
Published: (2023-11-01) -
Metastatic Breast Cancer: Review of Emerging Nanotherapeutics
by: Ranga Dissanayake, et al.
Published: (2023-05-01) -
Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma
by: Alessandro Allegra, et al.
Published: (2021-02-01)